FindTrial
Sign In

Prospective, randomized, multicenter clinical trial of cisplatin concurrent chemotherapy for single-week versus three-weeks regimens of locally advanced cervical cancer with radical chemoradiotherapy

Prospective, randomized, multicenter clinical trial of cisplatin concurrent chemotherapy for single-week versus three-weeks regimens of locally advanced cervical cancer with radical chemoradiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010374
Enrollment
Unknown
Registered
2017-01-10
Start date
2017-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Group A:Cisplatin concurrent chemotherapy for single-week
Group B:Cisplatin concurrent chemotherapy for three-weeks

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old; 2. KPS=60; 3. Pathologically confirmed cervical cancer; 4. FIGO staging locally advanced cervical cancer (1B2/2A2/2B and above); 5. Received the radical radio-chemotherapy; 6. The brachytherapy combined with external radiotherapy; 7. The external radiotherapy including the three-dimensional conformal external beam radiotherapy or IMRT technology.

Exclusion criteria

Exclusion criteria: 1. Previous or concomitant other cancers; 2. Other serious illnesses; 3. Failure to follow-up after treatment; 4. The data is missing or incomplete.

Design outcomes

Primary

MeasureTime frame
Local control rate;Cancer recurrence rate;Normal tissue side effects;Overall Survival;Progression-Free Survival;Quality of life;—

Countries

China

Contacts

Public ContactCheng Guanghui

China-Japan Union Hospital of Jilin University

chengghcjuh@sina.com+86 13504334509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026